Czechia – Antineoplastic agents – Cytostatic, tyrosine kinase inhibitor with the active substance Crizotinib
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
The subject of the performance of the public contract is the ongoing and repeated supplies of the medicinal product "Cytostatic, tyrosine kinase inhibitor with the active substance Crizotinib in strengths of 200 mg and 250 mg in 1 hard capsule (hereinafter referred to as "LP"), in accordance with the ZD and its annexes.